Thieno [3, 2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer

Details for Australian Patent Application No. 2009322270 (hide)

Owner Abbott Laboratories

Inventors Michaelides, Michael R.; Curtin, Michael, L.; Frey, Robin, R.

Agent Spruson & Ferguson

Pub. Number AU-A-2009322270

PCT Pub. Number WO2010/065825

Priority 61/120,281 05.12.08 US; 61/223,760 08.07.09 US

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/065825 Priority application(s): WO2010/065825

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322274-Hood method and device for material dissection

2009322269-Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases